Proposed LCD DL40222: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer — Noridian
Policy LCD-DL40222 · Oncology
Impact on billing for targeted molecular panel tests.
Code intelligence
C77.9 reimbursement alerts
Policy changes, MAC LCD updates, and CMS guidance matched to code C77.9.
Elevated code riskView ICD-10 detail
Signal breakdown
3 shown · 3 total in platform
Risk: Elevated
0
Critical
0%
1
High
33%
2
Routine
67%
0
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
High
LCD L36353: Lab: Special Histochemical Stains and Immunohistochemical Stains — Noridian
Policy LCD-L36353 · Clinical Laboratory
New LCD impacts lab billing for histochemical stains.
LCD L39686: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers — Noridian
Policy LCD-L39686 · Oncology
Key updates for prostate cancer decision-making tests.
Audit documentation
Building an audit file that includes C77.9?
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.
Get the Oncology audit pack — $349One-time purchase · not a subscription